- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07260903
Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Controlled Trial.
As people age, changes in balance and memory can make daily life more difficult and increase the risk of falls. Falls are one of the main causes of injury, hospitalization and loss of independence in older adults, while even mild declines in memory and concentration can reduce confidence, social participation and overall quality of life. Therefore, safe, affordable, and practical ways to help older adults remain steady on their feet and mentally sharp are urgently needed.
The aim of this project is therefore to conduct a pilot feasibility randomized controlled trial to examine whether regular home-based photobiomodulation can improve balance and cognitive function in adults aged over 60. If successful, this research could help shape future strategies for preventing falls, enhancing wellbeing and maintaining independence in older people.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jonathan Sinclair, DSc
- Phone Number: 07875651533
- Email: jksinclair@lancashire.ac.uk
Study Locations
-
-
Lancashire
-
Preston, Lancashire, United Kingdom, PR4 0PE
- Recruiting
- University of Central Lancashire
-
Contact:
- Jonathan Sinclair, DSc
- Phone Number: 07875651533
- Email: jksinclair@lancashire.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged from 60-80 years
- Ability to complete written questionnaires independently
- Able to provide informed consent
Exclusion Criteria:
- Current or past history of head injury
- Use of medications acting on the central nervous system
- Active skin conditions on the forehead or scalp
- Ongoing brain stimulation therapy
- History of migraines
- Sensitive skin, allergies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Sham photobiomodulation
8-weeks sham photobiomodulation. The sham device will follow the same protocol but without active light emission. |
The sham device will follow the same protocol but without active light emission.
|
|
Experimental: Photobiomodulation
8-weeks photobiomodulation Twenty-four-minute photobiomodulation stimulation (twelve minutes at 670 nm followed by twelve minutes at 810 nm). Three times per week for 8-weeks. |
8-weeks photobiomodulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
n-1-back (deviation)
Time Frame: Baseline
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
|
Baseline
|
|
n-1-back (deviation)
Time Frame: 1 hour
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
|
1 hour
|
|
n-1-back (deviation)
Time Frame: 8-weeks
|
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
|
8-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory
Time Frame: Baseline
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
|
Baseline
|
|
n-2-back (deviation)
Time Frame: Baseline
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
|
Baseline
|
|
n-2-back (deviation)
Time Frame: 1 hour
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
|
1 hour
|
|
n-2-back (deviation)
Time Frame: 8-weeks
|
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
|
8-weeks
|
|
n-1-back (post-deviation)
Time Frame: Baseline
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
|
Baseline
|
|
n-1-back (post-deviation)
Time Frame: 1 hour
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
|
1 hour
|
|
n-1-back (post-deviation)
Time Frame: 8-weeks
|
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
|
8-weeks
|
|
n-2-back (post-deviation)
Time Frame: Baseline
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
|
Baseline
|
|
n-2-back (post-deviation)
Time Frame: 1 hour
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
|
1 hour
|
|
n-2-back (post-deviation)
Time Frame: 8-weeks
|
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
|
8-weeks
|
|
n-1-back (post-target)
Time Frame: Baseline
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
|
Baseline
|
|
n-1-back (post-target)
Time Frame: 1 hour
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
|
1 hour
|
|
n-1-back (post-target)
Time Frame: 8-weeks
|
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
|
8-weeks
|
|
n-2-back (post-target)
Time Frame: Baseline
|
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
|
Baseline
|
|
n-2-back (post-target)
Time Frame: 1 hour
|
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
|
1 hour
|
|
n-2-back (post-target)
Time Frame: 8-weeks
|
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
|
8-weeks
|
|
n-1-back (load)
Time Frame: Baseline
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
|
Baseline
|
|
n-1-back (load)
Time Frame: 1 hour
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
|
1 hour
|
|
n-1-back (load)
Time Frame: 8-weeks
|
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
|
8-weeks
|
|
n-2-back (post-load)
Time Frame: Baseline
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
|
Baseline
|
|
n-2-back (post-load)
Time Frame: 1 hour
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
|
1 hour
|
|
n-2-back (post-load)
Time Frame: 8-weeks
|
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
|
8-weeks
|
|
Coop-Wonka chart
Time Frame: Baseline
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
|
Baseline
|
|
Coop-Wonka chart
Time Frame: 1 hour
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
|
1 hour
|
|
Coop-Wonka chart
Time Frame: 8-weeks
|
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
|
8-weeks
|
|
Beck Depression Inventory
Time Frame: 1 hour
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
|
1 hour
|
|
Beck Depression Inventory
Time Frame: 8-weeks
|
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
|
8-weeks
|
|
Pittsburgh Sleep Quality Index
Time Frame: Baseline
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components.
Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
|
Baseline
|
|
Pittsburgh Sleep Quality Index
Time Frame: 1 hour
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components.
Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
|
1 hour
|
|
Pittsburgh Sleep Quality Index
Time Frame: 8-weeks
|
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components.
Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
|
8-weeks
|
|
State Trait Anxiety Inventory
Time Frame: Baseline
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
|
Baseline
|
|
State Trait Anxiety Inventory
Time Frame: 1 hour
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
|
1 hour
|
|
State Trait Anxiety Inventory
Time Frame: 8-weeks
|
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
|
8-weeks
|
|
Insomnia Severity Index
Time Frame: Baseline
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia.
The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
|
Baseline
|
|
Insomnia Severity Index
Time Frame: 1 hour
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia.
The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
|
1 hour
|
|
Insomnia Severity Index
Time Frame: 8-weeks
|
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia.
The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
|
8-weeks
|
|
Epworth Sleepiness Scale
Time Frame: Baseline
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions.
Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
|
Baseline
|
|
Epworth Sleepiness Scale
Time Frame: 1 hour
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions.
Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
|
1 hour
|
|
Epworth Sleepiness Scale
Time Frame: 8-weeks
|
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions.
Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
|
8-weeks
|
|
Everyday Memory Errors Questionnaire
Time Frame: Baseline
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life.
It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
|
Baseline
|
|
Everyday Memory Errors Questionnaire
Time Frame: 1 hour
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life.
It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
|
1 hour
|
|
Everyday Memory Errors Questionnaire
Time Frame: 8-weeks
|
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life.
It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
|
8-weeks
|
|
Falls Efficacy
Time Frame: Baseline
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling.
It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
|
Baseline
|
|
Falls Efficacy
Time Frame: 1 hour
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling.
It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
|
1 hour
|
|
Falls Efficacy
Time Frame: 8-weeks
|
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling.
It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
|
8-weeks
|
|
Anterior-posterior balance
Time Frame: Baseline
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
|
Baseline
|
|
Anterior-posterior balance
Time Frame: 1 hour
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
|
1 hour
|
|
Anterior-posterior balance
Time Frame: 8-weeks
|
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
|
8-weeks
|
|
Medio-lateral balance
Time Frame: Baseline
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
|
Baseline
|
|
Medio-lateral balance
Time Frame: 1 hour
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
|
1 hour
|
|
Medio-lateral balance
Time Frame: 8-weeks
|
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
|
8-weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PMB balance and cognition
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Age >60
-
University Medical Center GroningenCompletedOverweight | Healthy Volunteers | Age Group: 60-70Netherlands
-
Universidad de ZaragozaIngesan-OHLACompletedPeople 60 Years of Age or Over 55 Years of Age With a Diagnosed Pathology and Preferably With a Recognized Physical and/or Cognitive DependencySpain
-
Korea UniversityCompletedApparently Healthy Elderly People | (Between 60-92 Years of Age)Korea, Republic of
-
First Affiliated Hospital of Zhejiang UniversityAbbVieRecruitingNewly Diagnosed Acute Myeloid Leukemia (AML) | Intensive Chemotherapy Unfit | Age ≥60China
-
Oklahoma State UniversityCompletedOver Age 60 | Prediabetes or OverweightUnited States
-
Ondokuz Mayıs UniversityRecruitingOlder Adults (60 - 85 Years Old)Turkey (Türkiye)
-
Taipei Medical UniversityNational Health Research Institutes, TaiwanCompleted
-
KTO Karatay UniversityRecruitingOlder Adults (60 - 85 Years Old)Turkey (Türkiye)
-
University of VermontNot yet recruitingOlder Adults (60 - 85 Years Old)
-
University Hospital Southampton NHS Foundation...CompletedOlder Adults (60 - 85 Years Old)United Kingdom
Clinical Trials on Sham 8-weeks photobiomodulation
-
University of Nove de JulhoNot yet recruiting
-
University of Nove de JulhoNot yet recruiting
-
University of Nove de JulhoNot yet recruiting
-
University of Nove de JulhoRecruiting
-
University of Nove de JulhoUnknownSoft Tissue Injuries
-
Universidade Federal de Sao CarlosThe São Paulo Research Foundation (FAPESP)Recruiting
-
Vita CareTegos S.A.CompletedOsteoarthritis | Osteoarthritis Hand | Osteoarthritis Finger | Osteoarthritis Both HandsBrazil
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity Disorder | Cognitive Deficit | Wellness | Attention Difficulties | Attention DeficitUnited States
-
University of ValenciaGeneralitat ValencianaRecruitingBreast Cancer Female | Autonomic Dysfunction | Cardiovascular Diseases in Old Age | Cardiometabolic Syndrome | Metabolism Disorder, LipidSpain
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States